Department of Pharmaceutical Sciences, School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA.
Department of Natural Sciences, School of Agriculture and Natural Sciences, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA.
J Cell Sci. 2017 Nov 1;130(21):3740-3748. doi: 10.1242/jcs.204222. Epub 2017 Sep 15.
Thyroid hormones (THs) and their DNA-binding nuclear receptors (TRs) direct transcriptional regulation in diverse ways depending on the host cell environment and specific promoter characteristics of TH-sensitive genes. This study sought to elucidate the impact on transcriptional repression of nucleotide sequence or orientation within TR binding sites - the TH response elements (TREs) of TH-sensitive promoters - to better understand ligand-dependent transcriptional repression of wild-type promoters. Computational analysis of the HSV-1 thymidine kinase (TK) gene TRE bound by TR and retinoid X receptor (RXR) revealed a single TRE point mutation sufficient to reverse the TRE orientation. experiments showed that the TRE point mutation had distinct impacts on promoter activity, sufficient to reverse the TH-dependent negative regulation in neuroendocrine differentiated cells. This point mutation altered the promoter's regulatory mechanism by discrete changes in transcription factor TR occupancy and altered enrichment of the repressive chromatin modification of histone-3-lysine-9-trimethyl (H3K9Me3). Insights relating to this negative TRE (nTRE) mechanism aids our understanding of other nTREs and TRE mutations associated with TH and herpes diseases.
甲状腺激素 (THs) 及其 DNA 结合核受体 (TRs) 根据宿主细胞环境和 TH 敏感基因特定启动子特征,以不同方式直接进行转录调控。本研究旨在阐明 TR 结合位点(TH 敏感启动子的 TH 反应元件 (TRE))内核苷酸序列或方向对转录抑制的影响,以更好地理解野生型启动子的配体依赖性转录抑制。通过计算分析 HSV-1 胸苷激酶 (TK) 基因 TRE 与 TR 和视黄酸 X 受体 (RXR) 的结合,发现单个 TRE 点突变足以逆转 TRE 方向。实验表明,TRE 点突变对启动子活性有明显影响,足以逆转神经内分泌分化细胞中 TH 依赖性负调控。该点突变通过转录因子 TR 占有率的离散变化和组蛋白-3-赖氨酸-9-三甲基 (H3K9Me3) 的抑制性染色质修饰的富集改变,改变了启动子的调节机制。与这种负 TRE(nTRE)机制相关的见解有助于我们理解与 TH 和疱疹疾病相关的其他 nTRE 和 TRE 突变。